Crossing finish line @bikeVeloSano @ClevelandClinic
Deepa Jagadeesh, MD retweeted
Congratulations to @DeepJagMD for representing #CleClinicCancer in the newly-published results of Pirtobrutinib in NEJM. Great to have more access to this important new treatment for our patients with #CLL, #CLLSociety nejm.org/doi/full/10.1056/NE…
Deepa Jagadeesh, MD retweeted
Folks it doesn’t get any better than moments like this - the spontaneous teamwork to get this silly picture going was ✨
📸me, June 2023
🍷none other than Dr. David Adelstein, circa 2011 🐐
Deepa Jagadeesh, MD retweeted
Just out! Outstanding work from Jessie Xu,DUSP22rearrangement generally positive for CD15, CD8, and less frequently expressed pSTAT3Tyr705 a distinctive immunophenotype but lower OS compared to ALK + ALCL: Haematologica haematologica.org/article/vi….
Deepa Jagadeesh, MD retweeted
Inspiring speech by @perez_protto @CleClinicMD
@theWPSA President 2023
Ask “What can women add to the organization” not the other way around. @TomMihaljevicMD @beridgeway @RitaPappasMD @DeepJagMD @smitha42 @jamecancerdoc @JLGeigerMD
Deepa Jagadeesh, MD retweeted
Such an inspiring event @WPSA1 Nnual meeting @CleClinicMD Remarkable to see so many women in leadership! @DeepJagMD @smitha42 @FunchainMD @JLGeigerMD @RitaPappasMD #HeForShe @jamecancerdoc @beridgeway @perez_protto
Great event supporting women staff at Cleveland clinic @ClevelandClinic @CleClinicMD @RitaPappasMD @WPSA1
Deepa Jagadeesh, MD retweeted
Congratulations and thanks to our outstanding colleagues, leadership of Josalyn Meyer ( Director of Nursing) Physician leaders like @DeepJagMD - opening of the beautiful, renovated inpatient Lymphoma Myeloma Service @ClevelandClinic @CleClinicMD
Deepa Jagadeesh, MD retweeted
Globally only 30% of researchers are women vs 70% of NBCA’s Council of Emerging Researchers in Thrombosis. Bravo to @dangeliniMD & @rushadpatell for helping close the #gendergap! stoptheclot.org/council-of-e…
#womenandgirlsinscience #stoptheclot @WomenScienceDay @ClevelandClinic
Incidence of secondary heme malignancies in CLL. Awesome job Rahul! @RahulMishraMBBS @AgrimaMianMD @paolocaimiMD #CleClinicCanc @CleClinicMD #ASH22
Long term follow up of RATHL trial confirmed omitting bleo had no impact on outcomes. Secondary cancers more in ABVD/AVD compared to BEACOPP, which is surprising. @StefanoLuminari #ASH22 @CleClinicMD
A-HIPI new prognostic score for advanced stage HL! Great work. @AngieRodday @DrAEvens #ASH22 @CleClinicMD
CR to RICE predicts better outcome in early relapse DLBCL @CaimiPaolo #ASH22 #CleClinicCan @CleClinicMD


































